Trials / Unknown
UnknownNCT00127049
Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
A Prospective Multicenter Phase II Trial of Gemcitabine, Cisplatin, and Ifosfamide (GIP) in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors (NSGCT) and a Predicted Favorable Prognosis
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 37 (planned)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- Male
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective multicenter phase II trial of gemcitabine, cisplatin, and ifosfamide (GIP) in patients with relapsed non-seminomatous germ-cell tumors (NSGCT) and a predicted favorable prognosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gemcitabine, ifosfamide, cisplatin, G-CSF |
Timeline
- Start date
- 2004-12-01
- First posted
- 2005-08-05
- Last updated
- 2006-09-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00127049. Inclusion in this directory is not an endorsement.